5-Chloro-4-(trifluoromethyl)pyridin-2-amine, 95.0%, 10g

Tetradecamethylhexasiloxane, 95%, 50g

5-Bromo-2-nitroisonicotinic acid, 95.0%, 100mg

2-Bromobenzene-1,3-dialdehyde, 98.0%, 5g

(S)-METHYL 2-(N-((2'-(1H-TETRAZOL-5-YL)-[1,1'-BIPHENYL]-4-YL)METHYL)PENTANAMIDO)-3-METHYLBUTANOATE, 95%, 100g

N-(Piperidin-4-yl)-6-(trifluoromethyl)pyrimidin-4-amine dihydrochloride, 1g

tert-butyl 3-(propan-2-yl)-2H,4H,5H,6H,7H-pyrazolo[4,3-c]pyridine-5-carboxylate, 95%, 5g

N-(4-Methoxyphenyl)acetamide, 98.0%, 5g

(S)-2-(2,5-Difluorophenyl)pyrrolidine hydrochloride, 97.0%, 5g

6-Bromo-1-methyl-1,2,3,4-tetrahydroquinoxaline, 95.0%, 5g

1-Butyl-3-methyl-imidazolium-, hexafluorophosphate, min. 99%, 100 g, glass packaging

n-(3-Bromophenyl)piperidin-3-amine, 98%, 100mg

5-(Ethoxycarbonyl)pyrazine-2-carboxylic acid, 100g